What diseases can resmetirom mainly treat?

Resmetirom - Rezdiffra is a new drug targeting liver lipid metabolism. Its core application is in adult patients with non-alcoholic steatohepatitis (NASH) and moderate to severe liver fibrosis. NASH is a chronic liver disease caused by liver fat deposition and inflammatory response. Without intervention, it may progress to cirrhosis or end-stage liver disease. Resmetirol regulates liver lipid and cholesterol metabolism by selectively activating thyroid beta receptors (THR-β), reducing liver fat content, reducing inflammation, improving the fibrosis process, and fundamentally improving liver structure and function.

This mechanism of action makes rismetirol different from traditional auxiliary drugs for liver diseases. It is not only a symptomatic treatment, but also intervenes in the disease itself through metabolic regulation. Clinical studies have shown that rismetirol has a significant effect in reducing liver fat, improving blood lipid profiles and reducing liver inflammation, so it is suitable for patients with moderate to severe liver fibrosis (F2 to F3 stages). It should be emphasized that this drug is not suitable for use in patients with decompensated cirrhosis, as liver function is severely impaired and may not be able to metabolize the drug safely.

In addition to drug therapy, the use of rismetirol must be combined with lifestyle intervention, including a low-calorie diet, reasonable protein intake, and regular exercise. Relying solely on drugs has limited effect, but combined intervention can significantly delay the progression of NASH and reduce the risk of developing cirrhosis or liver cancer. For early-stage patients, through a combination of drugs and lifestyle, it is possible to achieve disease management and improve quality of life without liver transplantation.

In short, rismetirol is targeted at patients with noncirrhoticNASH, especially those with fibrosis progression. By regulating liver lipid metabolism and reducing inflammation, it intervenes at the root cause of the disease rather than just relieving symptoms.

Reference materials:https://www.drugs.com/monograph/resmetirom.html